COMMUNIQUÉS West-GlobeNewswire

Carbios présente ses résultats semestriels 2026
24/09/2026
Réduction des dépenses opérationnelles de 19 % par rapport au 1 er semestre 2025, reflétant la discipline financière du Groupe Solide position de trésorerie de 48 millions d’euros au 30 juin 2026, permettant à Carbios [...]
Carbios reports first-half 2026 results
24/09/2026
19 % reduction in operating expenses compared with the first half of 2025, reflecting the financial discipline of the Group Solid cash position of €48 million as of June 30, 2026, enabling Carbios to cover its operating [...]
Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress
24/09/2026
Final Phase 2a data from the BIRCH trial of BIOX-101 in acute intracerebral hemorrhage, selected for a Late-Breaking Science oral presentation New data show statistically significant improvements across multiple [...]
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
24/09/2026
Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has [...]
Reminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7
24/09/2026
September 24, 2026 News release Reminder: Register Now | Unlocking the Growth - BioPorto Investor Meeting, October 7 As BioPorto continues to advance its commercial strategy and capitalize on emerging clinical [...]
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
24/09/2026
BOOST Pharma (“BOOST” or “the Company”), a clinical‑stage biopharmaceutical company developing novel, first‑in‑class off-the-shelf cell therapies for rare, debilitating pediatric skeletal diseases, today announced that [...]
Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer
24/09/2026
More than half of the patients planned for the clinical study have already been enrolled, with the trial progressing rapidly through dose escalation Advancement of ONA-255 marks an important milestone following Ona's $ [...]
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines
24/09/2026
BEIJING, Sept. 24, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company [...]
EssilorLuxottica et Meta continuent de développer la catégorie des lunettes IA avec de nouveaux produits, dévoilés lors de Meta Connect
24/09/2026
EssilorLuxottica et Meta continuent de développer la catégorie des lunettes IA avec de nouveaux produits, dévoilés lors de Meta Connect Les deux entreprises lancent une nouvelle gamme de lunettes IA audio et une [...]
EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect
24/09/2026
EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect The two companies introduce new line of audio AI glasses and next generation of Ray-Ban Meta, the world’s leading [...]
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026
24/09/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of [...]
MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter
23/09/2026
Court Vacates FDA Determinations That AXIOFILL Is Not Minimally Manipulated and Should Be Classified as a Biological Product Order Further Holds That Minimal-Manipulation Analysis Must Consider Tissue Characteristics [...]
Zymeworks Completes Acquisition of Theravance Biopharma
23/09/2026
Conference call with Zymeworks management on September 28 at 8:30 am Eastern Time (ET) VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a [...]
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026
23/09/2026
RADNOR, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
23/09/2026
NORTH PALM BEACH, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments [...]
Park Dental Partners Expands Arizona Presence with Addition of Sapphire Dental Care
23/09/2026
MINNEAPOLIS, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, announced that the single practice Sapphire Dental Care and its three (3) doctors joined [...]
CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
23/09/2026
The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care SAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today reinforced its commitment to [...]
Precision Optics Schedules Fourth Quarter and Fiscal Year 2026 Conference Call for September 28, 2026
23/09/2026
LITTLETON, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress"
23/09/2026
Featuring Serina Therapeutics’ CEO - Thursday, September 24, 2026 10M people in the world currently living with Parkinson’s disease with no major clinical advances in 50+ years Meet with Serina’s CEO Steven Ledger [...]

Pages